CLGNCollPlant Biotechnologies Ltd - Ordinary Shares New
CLGN
CollPlant Biotechnologies Ltd - Ordinary Shares New616
Mkt Cap
$5.51MVolume
60,142.0052W High
$4.9852W Low
$0.3173PE Ratio
-0.41CLGN Fundamentals
Price
$0.382Prev Close
$0.384Open
$0.387850D MA
$0.7166Beta
0.41Avg. Volume
33,357.72EPS (Annual)
-$0.9415P/B
0.80Rev/Employee
$60,794.87$13.98
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE PR Newswire REHOVOT, Israel, March 26, 2026 REHOVOT, Israel, March 26, 2026 /PRNewswire/ -- CollPlantBiotechnologies (Nasdaq...
PR Newswire·16d ago
CollPlant Biotechnologies Receives Nasdaq Notification Regarding Minimum Bid Requirement
CollPlant Biotechnologies Receives Nasdaq Notification Regarding Minimum Bid Requirement CollPlant Biotechnologies Receives Nasdaq Notification Regarding Minimum Bid Requirement PR Newswire REHOVOT...
PR Newswire·18d ago
CollPlant Biotechnologies Launches Redesigned Corporate Website
CollPlant Biotechnologies Launches Redesigned Corporate Website CollPlant Biotechnologies Launches Redesigned Corporate Website PR Newswire REHOVOT, Israel, March 18, 2026 REHOVOT, Israel, March 18...
PR Newswire·24d ago
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FULL YEAR 2025 FINANCIAL RESULTS
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FULL YEAR 2025 FINANCIAL RESULTS COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FULL YEAR 2025 FINANCIAL RESULTS PR Newswire REHOVOT, Israel, March 11, 2026...
PR Newswire·1mo ago
CollPlant Biotechnologies Announces Korean Patent Allowance Secured for its Photocurable Dermal Filler
CollPlant Biotechnologies Announces Korean Patent Allowance Secured for its Photocurable Dermal Filler CollPlant Biotechnologies Announces Korean Patent Allowance Secured for its Photocurable Dermal...
PR Newswire·1mo ago
CollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-to-Print BioFlex
CollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-to-Print BioFlex CollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-to-Print BioFlex PR Newswire...
PR Newswire·2mo ago
CollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-Loss Treatments
CollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-Loss Treatments CollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-Loss Treatments PR Newswire REHOVOT, Israel, Feb. 17, 2026...
PR Newswire·2mo ago
COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.0 MILLION REGISTERED DIRECT OFFERING
COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.0 MILLION REGISTERED DIRECT OFFERING COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.0 MILLION REGISTERED DIRECT OFFERING PR Newswire REHOVOT, Israel, Feb. 5, 2026...
PR Newswire·2mo ago
CLGN Stock Crashed 14% Today – Disappointing Earnings, Workforce Reduction Plan Draws Investor Attention
The firm reported revenue of $77,000 for the three months ended September, above the $4,000 reported in the corresponding quarter of 2024, but below an analyst estimate of $5.03 million, according to data from Fiscal AI.
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE...
PR Newswire·5mo ago
<
1
2
...
>